Abstract:Association between COL11A1 loci and DDH was identified with GWAS and exome sequencing. ScRNA‐seq for DDH and Col11a1‐KO cartilage demonstrated disrupted chondrocyte homeostasis and cellular senescence caused by glycolysisOXPHOS metabolism shift in chondrocytes. Genetically inspired, an intra‐articular injection therapy was fabricated to prevent cartilage degeneration with Col11a1‐OE SMSC organoids. Col11a1‐OE organoids ameliorated cartilage degeneration and inhibited cellular senescence by up‐regulated Col11a1/HIF1 α‐mediated glycolysis in chondrocytes. Introduction Developmental dysplasia of hip (DDH) is a hip joint disorder leading to subsequent osteoarthritis. Previous studies suggested collagen XI alpha 1 (COL11A1) as a potential gene in hip dysplasia and chondrocyte degeneration. However, no genetic association has reported COL11A1‐related cellular therapy as treatment of DDH and joint degeneration. Methods and Results We report identified genetic association between COL11A1 locus and DDH with genome‐wide association study (GWAS). Further exome sequencing for familial DDH patients was conducted in different populations to identify potential pathogenic Col11A1 variants for familiar DDH. Further studies demonstrated involvement of COL11A1 expression was down‐regulated in femoral head cartilage of DDH patients and Col11a1‐KO mice with induced DDH. Col11a1‐KO mice demonstrated aggravated joint degeneration and severe OA phenotype. To explore the underlying mechanism of Col11a1 in cartilage and DDH development, we generated scRNA‐seq profiles for DDH and Col11a1‐KO cartilage, demonstrating disrupted chondrocyte homeostasis and cellular senescence caused by Col11a1–HIF1α‐mediated glycolysis–OXPHOS shift in chondrocytes. Genetically and biologically inspired, we further fabricated an intra‐articular injection therapy to preventing cartilage degeneration by generating a Col11a1‐over‐expressed (OE) SMSC mini‐organoids. Col11a1‐OE organoids demonstrated superior chondrogenesis and ameliorated cartilage degeneration in DDH mice via regulating cellular senescence by up‐regulated Col11a1/HIF1α‐mediated glycolysis in chondrocytes. Conclusion We reported association between COL11A1 loci and DDH with GWAS and exome sequencing. Further studies demonstrated involvement of COL11A1 in DDH patients and Col11a1‐KO mice. ScRNA‐seq for DDH and Col11a1‐KO cartilage demonstrated disrupted chondrocyte homeostasis and cellular senescence caused by Col11a1–HIF1α‐mediated glycolysis–OXPHOS shift in chondrocytes. Genetically and biologically inspired, an intra‐articular injection therapy was fabricated to prevent cartilage degeneration with Col11a1‐OE SMSC organoids. Col11a1‐OE organoids ameliorated cartilage degeneration in DDH mice via regulating cellular senescence by up‐regulated Col11a1/HIF1α‐mediated glycolysis in chondrocytes.

Comprehensive analysis of pathological changes in hip joint capsule of patients with developmental dysplasia of the hip

Inflammatory and Fibrosis Infiltration in Synovium Associated with the Progression in Developmental Dysplasia of the Hip.

Severe cartilage degeneration in patients with developmental dysplasia of the hip

Expression of Platelet-Derived Growth Factor-a in the Hip Capsule of Children with Developmental Dysplasia of the Hip

Microstructure Changes and Mirna-Mrna Network in a Developmental Dysplasia of the Hip Rat Model

Research progress in the prevention and treatment of developmental dysplasia of the hip

Integrative Analysis of MicroRNA and mRNA Sequencing Data Identifies Novel Candidate Genes and Pathways for Developmental Dysplasia of Hip

Morphological Analysis of the Knee Joint in Patients with Hip Dysplasia.

Early Emergent and Progressive Aberrant Subchondral Bone Remodeling Coupled with Aggravated Cartilage Degeneration in Developmental Dysplasia of the Hip

Single-nucleus RNA and Multiomics in Situ Pairwise Sequencing Reveals Cellular Heterogeneity of the Abnormal Ligamentum Teres in Patients with Developmental Dysplasia of the Hip

Increasing Expression of Substance P and Calcitonin Gene-Related Peptide in Synovial Tissue and Fluid Contribute to the Progress of Arthritis in Developmental Dysplasia of the Hip

Review of susceptibility genes in developmental dysplasia of the hip: A comprehensive examination of candidate genes and pathways

Identification of KANSL1 as a novel pathogenic gene for developmental dysplasia of the hip

Impaired Ossification Coupled with Accelerated Cartilage Degeneration in Developmental Dysplasia of the Hip: Evidences from Μct Arthrography in a Rat Model

Cyclic Compressive Stress-Induced Scinderin Regulates Progress of Developmental Dysplasia of the Hip

Association Between Anterior Hip Capsule Thickening and Sagittal Pelvic Alignment Among Patients With Developmental Dysplasia of the Hip

[One Family Investigation and Risk Factors Analysis of Developmental Dysplasia of the Hip].

Specificities in the Structure of the Cartilage of Patients with Advanced Stages of Developmental Dysplasia of the Hip

Genetically inspired organoids prevent joint degeneration and alleviate chondrocyte senescence via Col11a1–HIF1α‐mediated glycolysis–OXPHOS metabolism shift

Genetic Study on Developmental Dysplasia of the Hip.

Whole Genome Sequencing of Pairwise Human Subjects Reveals DNA Mutations Specific to Developmental Dysplasia of the Hip.